Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A400P4 | ISIN: VGG6146G1090 | Ticker-Symbol:
NASDAQ
10.01.25
21:58 Uhr
4,170 US-Dollar
0,000
0,00 %
Branche
Dienstleistungen
Aktienmarkt
ASIEN
1-Jahres-Chart
MINT INCORPORATION LIMITED Chart 1 Jahr
5-Tage-Chart
MINT INCORPORATION LIMITED 5-Tage-Chart
GlobeNewswire (Europe)
29 Leser
Artikel bewerten:
(0)

Mint Inc Ltd: Mint Incorporation Limited Announces Pricing of $7 million Initial Public Offering and Listing on Nasdaq

Finanznachrichten News

Hong Kong, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) (the "Company"), a Hong Kong-based interior design and fit out works provider, today announced the pricing of its initial public offering (the "Offering") of 1,750,000 Class A ordinary shares (the "Class A Ordinary Shares"), at a price of $4.00 per Class A Ordinary Share (the "Offering Price").

The Class A Ordinary Shares are expected to begin trading on the Nasdaq Capital Market on January 10, 2025 under the symbol "MIMI." The Offering is expected to close on January 13, 2025, subject to the satisfaction of customary closing conditions.

The Company expects to receive aggregate gross proceeds of US$7 million from the Offering, before deducting the underwriting discounts and other related expenses. In addition, the Company has granted the Underwriters (as defined below) a 45-day option to purchase up to an additional 262,500 Class A Ordinary Shares of the Company, at the Offering Price, representing 15% of the Class A Ordinary Shares sold in the Offering (the "Over-allotment Option").

Assuming that the Over-allotment Option is not exercised, the Company is expected to receive net proceeds amounting to $4.80 million, after deducting the underwriting discounts and commissions and estimated offering expenses, assuming the underwriters do not exercise their Over-allotment Option. The Company intends to use the net proceeds for increasing operating scale and expanding business and geographic coverage including the United States of America and the United Kingdom, potential strategic investment and acquisitions, upgrading IT services, and working capital and general corporate purposes.

The Offering is conducted on a firm commitment basis. Benjamin Securities, Inc. is acting as the representative of the underwriters, with Prime Number Capital, LLC acting as co-underwriter (collectively, the "Underwriters") for the Offering. Ortoli Rosenstadt LLP is acting as U.S. securities counsel to the Company. Jun He Law Offices LLC is acting as legal counsel to the Underwriters in connection with the Offering.

The Offering is being conducted pursuant to the Company's Registration Statement on Form F-1 (File No. 333- 281922) previously filed with, and subsequently declared effective by the U.S. Securities and Exchange Commission (the "SEC") on December 20, 2024. The Offering is being made only by means of a prospectus. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies of the prospectus relating to the Offering may be obtained, when available, from Benjamin Securities, Inc. by email at info@benjaminsecurities.com, by standard mail to Benjamin Securities, Inc., 3 West Garden Street, Suite 407, Pensacola, FL 32502, or by telephone at +1 (516) 931-1090; or from Prime Number Capital, LLC by email at info@pncps.com, by standard mail to Prime Number Capital, LLC, 12 E 49 St, Floor 27, New York, NY 10017, or by telephone at +1 (516)717-5671.

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, and no sale of these securities may be made in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Mint Incorporation Limited

The Company is a Hong Kong-based interior design and fit out works provider, with a strategic focus on providing integrated and industry-specific interior design and fit out works for commercial properties. The Company's work encompasses offices of different industries and various kinds of retail stores with a view to reflect its customers' corporate values and conceptualizing our customers' brands. The Company's commercial projects cover internationally renowned retail stores, F&B outlet chains and offices and other premises of a premier charitable organization in Hong Kong. The Company also provides integrated interior design and fit out works for luxury residential properties in order to enhance both the aesthetics and functionality of the interior space.

FORWARD-LOOKING STATEMENTS

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations, including the trading of its Class A Ordinary Shares or the closing of the Offering. Investors can find many (but not all) of these statements by the use of words such as "approximates," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may" or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to read the risk factors contained in the Company's final prospectus and other reports it files with the SEC before making any investment decisions regarding the Company's securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.

Contacts

Mint Incorporation Limited
Investor Relations
Email: info@mimintinc.com
Phone: +852 2866 1663


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.